Physician profile
Audrey Sun
NPI 1699512590
$467.35
in general payments reported to CMS, 2019-2025
10 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $150 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $135.79 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $134.43 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $59.91 | 2024-2025 | Airsupra |
| Edwards Lifesciences Corporation | $34.43 | 2025 | Sapien 3 Ultra Resilia |
| Vivus LLC | $22.60 | 2024 | Qsymia |
| Exact Sciences Corporation | $17.65 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $16.80 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.25 | 2024 | |
| Inspire Medical Systems, INC. | $15.63 | 2025 | Inspire |
| Amgen INC. | $13.86 | 2025 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.